Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;22(11):1821-1829.
doi: 10.1038/s41436-020-0905-3. Epub 2020 Jul 16.

Participant choices for return of genomic results in the eMERGE Network

Affiliations

Participant choices for return of genomic results in the eMERGE Network

Christin Hoell et al. Genet Med. 2020 Nov.

Abstract

Purpose: Secondary findings are typically offered in an all or none fashion when sequencing is used for clinical purposes. This study aims to describe the process of offering categorical and granular choices for results in a large research consortium.

Methods: Within the third phase of the electronic MEdical Records and GEnomics (eMERGE) Network, several sites implemented studies that allowed participants to choose the type of results they wanted to receive from a multigene sequencing panel. Sites were surveyed to capture the details of the implementation protocols and results of these choices.

Results: Across the ten eMERGE sites, 4664 participants including adolescents and adults were offered some type of choice. Categories of choices offered and methods for selecting categories varied. Most participants (94.5%) chose to learn all genetic results, while 5.5% chose subsets of results. Several sites allowed participants to change their choices at various time points, and 0.5% of participants made changes.

Conclusion: Offering choices that include learning some results is important and should be a dynamic process to allow for changes in scientific knowledge, participant age group, and individual preference.

Keywords: disclosure; genetic research results; genetic testing; preferences; secondary findings.

PubMed Disclaimer

Conflict of interest statement

DISCLOSURE

W.K.C. serves on the Scientific Advisory Board of Regeneron Genetics Center. K.M. is a consultant for Novartis, as well as a coinventor and consultant for Hive Networks, Inc. The other authors declare no conflicts of interest.

References

    1. Daack-Hirsch S, Driessnack M, Hanish A, et al.‘Information is information’: a public perspective on incidental findings in clinical and research genome-based testing. Clin Genet. 2013;84:11–18. - PMC - PubMed
    1. Facio FM, Eidem H, Fisher T, et al.Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study. Eur J Hum Genet. 2013;21:261–265. - PMC - PubMed
    1. Jelsig AM, Qvist N, Brusgaard K, Ousager LB. Research participants in NGS studies want to know about incidental findings. Eur J Hum Genet. 2015;23:1423–1426. - PMC - PubMed
    1. Shahmirzadi L, Chao EC, Palmaer E, Parra MC, Tang S, Gonzalez KD. Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing. Genet Med. 2014;16:395–399. - PMC - PubMed
    1. Yu JH, Crouch J, Jamal SM, Tabor HK, Bamshad MJ. Attitudes of African Americans toward return of results from exome and whole genome sequencing. Am J Med Genet A. 2013;161a:1064–1072. - PMC - PubMed

Publication types

LinkOut - more resources